181 related articles for article (PubMed ID: 27588207)
1. Use of a new proximity assay (NanoBRET) to investigate the ligand-binding characteristics of three fluorescent ligands to the human
Soave M; Stoddart LA; Brown A; Woolard J; Hill SJ
Pharmacol Res Perspect; 2016 Oct; 4(5):e00250. PubMed ID: 27588207
[TBL] [Abstract][Full Text] [Related]
2. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
Sarsero D; Molenaar P; Kaumann AJ
Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
[TBL] [Abstract][Full Text] [Related]
3. Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP.
Gherbi K; Briddon SJ; Hill SJ
Br J Pharmacol; 2014 Dec; 171(23):5431-45. PubMed ID: 25052258
[TBL] [Abstract][Full Text] [Related]
4. Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation.
Gherbi K; May LT; Baker JG; Briddon SJ; Hill SJ
FASEB J; 2015 Jul; 29(7):2859-71. PubMed ID: 25837585
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody raised against a thermo-stabilised β
Soave M; Cseke G; Hutchings CJ; Brown AJH; Woolard J; Hill SJ
Biochem Pharmacol; 2018 Jan; 147():38-54. PubMed ID: 29102678
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology and direct visualisation of BODIPY-TMR-CGP: a long-acting fluorescent beta2-adrenoceptor agonist.
Baker JG; Hall IP; Hill SJ
Br J Pharmacol; 2003 May; 139(2):232-42. PubMed ID: 12770928
[TBL] [Abstract][Full Text] [Related]
7. NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing.
White CW; Johnstone EKM; See HB; Pfleger KDG
Cell Signal; 2019 Feb; 54():27-34. PubMed ID: 30471466
[TBL] [Abstract][Full Text] [Related]
8. New Horizons on Molecular Pharmacology Applied to Drug Discovery: When Resonance Overcomes Radioligand Binding.
Pernomian L; Gomes MS; Moreira JD; da Silva CHTP; Rosa JMC; Cardoso CRB
Curr Radiopharm; 2017; 10(1):16-20. PubMed ID: 28183248
[TBL] [Abstract][Full Text] [Related]
9. A Non-imaging High Throughput Approach to Chemical Library Screening at the Unmodified Adenosine-A
Arruda MA; Stoddart LA; Gherbi K; Briddon SJ; Kellam B; Hill SJ
Front Pharmacol; 2017; 8():908. PubMed ID: 29321740
[TBL] [Abstract][Full Text] [Related]
10. Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.
Kaumann AJ; Engelhardt S; Hein L; Molenaar P; Lohse M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):87-93. PubMed ID: 11191841
[TBL] [Abstract][Full Text] [Related]
11. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
12. Experimental determination of the bioluminescence resonance energy transfer (BRET) Förster distances of NanoBRET and red-shifted BRET pairs.
Weihs F; Wang J; Pfleger KDG; Dacres H
Anal Chim Acta X; 2020 Nov; 6():100059. PubMed ID: 33392495
[TBL] [Abstract][Full Text] [Related]
13. ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Brahmadevara N; Shaw AM; MacDonald A
Br J Pharmacol; 2004 Jun; 142(4):781-7. PubMed ID: 15205310
[TBL] [Abstract][Full Text] [Related]
14. NanoBRET Approaches to Study Ligand Binding to GPCRs and RTKs.
Stoddart LA; Kilpatrick LE; Hill SJ
Trends Pharmacol Sci; 2018 Feb; 39(2):136-147. PubMed ID: 29132917
[TBL] [Abstract][Full Text] [Related]
15. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
16. Competitive and non-competitive interactions between specific ligands and beta-adrenoceptors in living cardiac cells.
Porzig H; Becker C; Reuter H
Naunyn Schmiedebergs Arch Pharmacol; 1982 Nov; 321(2):89-99. PubMed ID: 6296703
[TBL] [Abstract][Full Text] [Related]
17. (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta 1-adrenoceptor.
Sarsero D; Russell FD; Lynham JA; Rabnott G; Yang I; Fong KM; Li L; Kaumann AJ; Molenaar P
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):10-21. PubMed ID: 12616336
[TBL] [Abstract][Full Text] [Related]
18. Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.
Schloos J; Wellstein A; Palm D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):48-59. PubMed ID: 2888026
[TBL] [Abstract][Full Text] [Related]
19. Complex Formation between VEGFR2 and the β
Kilpatrick LE; Alcobia DC; White CW; Peach CJ; Glenn JR; Zimmerman K; Kondrashov A; Pfleger KDG; Ohana RF; Robers MB; Wood KV; Sloan EK; Woolard J; Hill SJ
Cell Chem Biol; 2019 Jun; 26(6):830-841.e9. PubMed ID: 30956148
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
Germack R; Starzec AB; Vassy R; Perret GY
Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
